Genome-wide association studies (GWAS) in several populations have demonstrated significant association of the IL23R gene with IBD (Crohn's disease (CD) and ulcerative colitis (UC)) and psoriasis, suggesting that perturbation of the IL-23 signaling pathway is relevant to the pathophysiology of these diseases. One particular variant, R381Q (rs11209026), confers strong protection against development of CD. We investigated the effects of this variant in primary T cells from healthy donors carrying IL23R(R381) and IL23R(Q381) haplotypes. Using a proprietary anti-IL23R antibody, ELISA, flow cytometry, phosphoflow and real-time RT-PCR methods, we examined IL23R expression and STAT3 phosphorylation and activation in response to IL-23. IL23R(Q381) was associated with reduced STAT3 phosphorylation upon stimulation with IL-23 and decreased number of IL-23 responsive T-cells. We also observed slightly reduced levels of proinflammatory cytokine secretion in IL23R(Q381) positive donors. Our study shows conclusively that IL23R(Q381) is a loss-of-function allele, further strengthening the implication from GWAS results that the IL-23 pathway is pathogenic in human disease. This data provides an explanation for the protective role of R381Q in CD and may lead to the development of improved therapeutics for autoimmune disorders like CD.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192060 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0025038 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
IL23R mutations associated with decreased risk of psoriasis lead to the differential expression of genes implicated in the disease.
Exp Dermatol
September 2024
Manchester Academic Health Science Centre, Faculty of Biology Medicine and Health, School of Biological Sciences, The University of Manchester, Manchester, UK.
Article Synopsis
- * Researchers developed models using T cells to analyze how different forms of IL23R (wild type vs. protective mutant) impact the signaling pathway via STAT3, identifying genes related to psoriasis risk through RNA sequencing.
- * The study discovered several key genes (like HLA-B, SOCS1, and CCR5) that are differentially regulated based on IL23R form, contributing to a better understanding of the IL23 pathway and its role in psoriasis.
Interleukins (IL-23 and IL-27) serum levels: Relationships with gene polymorphisms and disease patterns in multiple sclerosis patients under treatment with interferon and glatiramer acetate.
Heliyon
June 2023
Department of Biochemistry, "Iuliu Hațieganu" University of Medicine and Pharmacy Cluj-Napoca, Cluj-Napoca, 400012, Romania.
Background: interleukin 23 (IL-23) is an important factor involved in the survival and proliferation of T helper 17 cells (Th17), known for their implication in multiple sclerosis (MS). By contrast, IL-27 regulates and modulates the function of T lymphocytes, in particular as a suppressor of Th17 differentiation. The aims of the study were i) to test the association of cytokines with the clinical and genetic characteristics in each of the multiple sclerosis groups (CIS - clinically isolated syndrome, RRMS - relapsing-remitting MS and SPMS - Secondary progressive MS) and ii) to evaluate the association between serum levels of IL-23 and IL-27 with (IL-27), (IL-27) and (IL-23) gene polymorphisms in RRMS patients.
View Article and Find Full Text PDFPotential Contribution of IL-27 and IL-23 Gene Polymorphisms to Multiple Sclerosis Susceptibility: An Association Analysis at Genotype and Haplotype Level.
J Clin Med
December 2021
Department of Biochemistry, "Iuliu Hațieganu" University of Medicine and Pharmacy Cluj-Napoca, 400000 Cluj-Napoca, Romania.
Article Synopsis
- - The study investigates the link between specific genetic variations (SNPs) in interleukin genes (IL-23 and IL-27) and the susceptibility to multiple sclerosis (MS), finding that these variations can significantly influence disease risk.
- - A case-control study with 252 participants identified that certain IL-27 gene variants increase the odds of developing MS, while variations in the IL-23 gene appear to decrease the risk.
- - The findings suggest that individuals with specific haplotypes related to these interleukins have a higher risk of developing MS, highlighting the importance of genetic factors in autoimmune disease susceptibility.
IL23 Promotes Antimicrobial Pathways in Human Macrophages, Which Are Reduced With the IBD-Protective IL23R R381Q Variant.
Cell Mol Gastroenterol Hepatol
November 2021
Section of Digestive Diseases, Department of Internal Medicine, Yale University, New Haven, Connecticut. Electronic address:
Background & Aims: Interleukin (IL)23 is a major contributor to inflammatory bowel disease (IBD) pathogenesis and is being pursued as a therapeutic target, both through targeting IL23 alone or in combination with IL12. Unexpected trial outcomes highlight the importance of understanding the cell types through which IL23 regulates immune responses, and how IL23 and IL12 compare in these responses. Macrophages are key players in IBD, and IL23 recently was found to promote inflammatory outcomes in human macrophages.
View Article and Find Full Text PDFObjective: The interleukin (IL)23 pathway contributes to IBD pathogenesis and is being actively studied as a therapeutic target in patients with IBD. Unexpected outcomes in these therapeutic trials have highlighted the importance of understanding the cell types and mechanisms through which IL23 regulates immune outcomes. How IL23 regulates macrophage outcomes and the consequences of the IL23R R381Q IBD-protective variant on macrophages are not well defined; macrophages are key players in IBD pathogenesis and inflammation.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!